Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye

Vaajanen A., Vapaatalo H., Kautiainen H., Oksala O.

2008
Investigative Ophthalmology and Visual Science

View publication

Therapeutic Area

Glaucoma
Categories

Preclinical development

Affiliations

Institute of Biomedicine, Pharmacology, University of Helsinki, Finland; Rheumatism Foundation Hospital, Heinola, Finland; Research and Development Division, Santen Oy, Tampere, Finland; Institute of Biomedicine, Pharmacology, University of Helsinki, PO Box 63, 00014 Helsinki, Finland

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group

Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

View all Glaucoma publications